8378511falsePharmaceutical services.2022-02-012023-01-31http://www.companieshouse.gov.uk/2022-01-31http://www.companieshouse.gov.uk/cd:Director12022-02-012023-01-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2022-02-012023-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-01-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2022-01-31http://www.companieshouse.gov.uk/2022-02-012023-01-31http://www.companieshouse.gov.uk/2022-01-31http://www.companieshouse.gov.uk/2023-01-31http://www.companieshouse.gov.uk/cd:FullAccounts2022-02-012023-01-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2022-02-012023-01-31http://www.companieshouse.gov.uk/cd:Micro-entities2022-02-012023-01-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 8378511

RAR Pharmaceutics Ltd

ACCOUNTS
FOR THE YEAR ENDED 31/01/2023

Prepared By:
Avalon Partners Ltd
35 Watling St Rd
Preston
PR2 8EA

RAR Pharmaceutics Ltd

Registered Number: 8378511
BALANCE SHEET AT 31/01/2023
20232022
££
Fixed assets604805
Current assets1,6852,412
Creditors: amounts falling due within one year(171)(1,352)
Net Current Assets1,5141,060
Total assets less current liabilities2,1181,865
Net Assets2,1181,865
Capital and reserves2,1181,865
Average Number of Employees
During the year the average number of employees was 1.
Company information
Private company limited by shares registered in EW - England and Wales, registered number 8378511. Registered office 18 Avenue Rd, Darlaston, West Midlands, WS10 8AR, UK
For the year ending 31/01/2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the micro-entities regime.
These accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 20/10/2023 and signed on their behalf by
.............................
R A Ravat
Director